2020 On-site
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
33 Arch St Fl 17, Boston, Massachusetts,...Phone Number
(617) 435-5632Website
www.2020onsite.comRevenue
<$5 MillionIndustry
About 2020 On-site
20/20 Onsite specializes in point-of-need ophthalmic clinical trial solutions, providing single-call accountability for ocular endpoints in clinical trials. With over 100,000 eye exams performed and a focus on reducing participant dropout rates, they support sponsors and CROs through all phases of clinical trials. Their services include recruitment, retention, and data integrity, ensuring successful trial outcomes while improving patient diversity and reducing travel burdens. The company is dedicated to delivering high-quality ophthalmic assessments directly to participants, enhancing the overall clinical trial experience.Explore more
2020 On-site Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to 2020 On-site
Compare insights from companies similar to 2020 On-site, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
2020 On-site Tech Stack
A closer look at the technologies used by 2020 On-site
Top Business Services Companies
Frequently Asked Questions Regarding 2020 On-site
Sign Up For FreeTo access detailed company insights
20/20 Onsite specializes in point-of-need ophthalmic clinical trial solutions, providing single-call accountability for ocular endpoints in clinical trials. With over 100,000 eye exams performed and a focus on reducing participant dropout rates, they support sponsors and CROs through all phases of clinical trials. Their services include recruitment... Read More
